Endocr Pract. 2019 May;25(5):491-502. doi: 10.4158/EP-2018-0506. Epub 2019 Jan 18.
It is still controversial as to how the reclassification of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) affects the risk of malignancy (ROM) in The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC). This meta-analysis was aimed to investigate the impact of NIFTP on the ROM in each TBSRTC category. We accessed three electronic databases including PubMed, Web of Science, and Scopus to search for relevant data from January, 2016 to July, 2018. Relative risk and meta-analysis of proportions using the DerSimonian-Laird method, and each corresponding 95% confidence interval (CI) was pooled using a random-effect model. A total of 14 studies consisting of 14,153 resected nodules were included for meta-analyses. Overall, there was a significant reduction in ROM in all TBSRTC categories following the NIFTP reclassification, except TBSRTC category I. The largest absolute and relative decrease in ROM was observed in TBSRTC category V (16%; 95% CI = 8 to 24) and category III (32%; 95% CI = 24 to 39), respectively. There was a positive correlation between the rate of NIFTP and resection rate (r = 0.83; = .02). The decreases in ROM were more prominent in Western than in Asian cohorts. We confirmed the decrease in ROM due to the NIFTP reclassification for most of TBSRTC categories, which was more significant in Western than in Asian practice. The incidence of NIFTP was higher in institutions where surgical resection rates were high in patients with indeterminate cytology nodules. = atypia of undetermined significance/follicular lesion of undetermined significance; = confidence interval; = fine-needle aspiration; = follicular neoplasm/suspicious for follicular neoplasm; = noninvasive follicular thyroid neoplasm with papillary-like nuclear features; = noninvasive follicular variant of papillary thyroid carcinoma; = risk of malignancy; = relative risk; = suspicious for malignancy; = The Bethesda System for Reporting Thyroid Cytopathology.
非浸润性滤泡甲状腺肿瘤伴乳头状核特征(NIFTP)的重新分类如何影响甲状腺细胞病理学报告的 Bethesda 系统(TBSRTC)中恶性肿瘤风险(ROM)仍存在争议。本荟萃分析旨在研究 NIFTP 对 TBSRTC 各分类中 ROM 的影响。我们检索了 PubMed、Web of Science 和 Scopus 这三个电子数据库,以从 2016 年 1 月至 2018 年 7 月间搜索相关数据。采用 DerSimonian-Laird 法计算相对风险和比例的荟萃分析,并使用随机效应模型对每个相应的 95%置信区间(CI)进行合并。共有 14 项研究(包括 14153 例切除结节)纳入荟萃分析。总体而言,除 TBSRTC 类别 I 外,NIFTP 重新分类后所有 TBSRTC 类别的 ROM 均显著降低。ROM 降幅最大的是 TBSRTC 类别 V(16%;95%CI=8%至 24%)和类别 III(32%;95%CI=24%至 39%)。NIFTP 发生率与切除率之间存在正相关(r=0.83;=0.02)。与亚洲队列相比,西方队列的 ROM 降低更为明显。我们证实了 NIFTP 重新分类导致大多数 TBSRTC 类别 ROM 降低,西方队列比亚洲队列更为显著。在对不确定细胞学结节患者进行手术切除率较高的机构中,NIFTP 的发生率更高。 = 意义不明确的非典型病变/滤泡性病变意义不明确; = 置信区间; = 细针穿刺抽吸术; = 滤泡性肿瘤/疑似滤泡性肿瘤; = 非浸润性滤泡甲状腺肿瘤伴乳头状核特征; = 非浸润性滤泡型甲状腺乳头状癌; = 恶性肿瘤风险; = 相对风险; = 疑似恶性肿瘤; = 甲状腺细胞病理学报告的 Bethesda 系统。